Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-06-21 @ 12:41 AM
Study NCT ID:
NCT01186458
Status:
TERMINATED
Last Update Posted:
2016-10-24
First Post:
2010-08-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Sponsor:
Hoosier Cancer Research Network
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma, Non-Hodgkin | View |
Keywords: